Patents by Inventor Adi Eisenberg

Adi Eisenberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7169411
    Abstract: A composition for facilitating delivery of biological agents, comprising a therapeutic or diagnostic agent and a supramolecular complex, the latter comprising (i) a block copolymer, having at least one nonionic, water soluble segment and at least one polyionic segment, and (ii) at least one charged surfactant having hydrophobic groups. The charge of the surfactant is opposite to the charge of the polyionic segment of the block copolymer. The constituents of the supramolecular complex are bound by interaction between the opposite charges thereof and between surfactant hydrophobic groups. The therapeutic or diagnostic agent may be an ionic substance, in which case the ionic substance has a net charge opposite to that of the block copolymer, the net charge being no more than 10.
    Type: Grant
    Filed: June 11, 1998
    Date of Patent: January 30, 2007
    Assignees: The University of Nebraska Board of Regents, McGill University, The Moscow State University
    Inventors: Alexander V. Kabanov, Adi Eisenberg, Victor A. Kabanov
  • Patent number: 7056532
    Abstract: A composition for facilitating delivery of biological agents, comprising a supramolecular complex including as constituents a block copolymer, having at least one nonionic, water soluble segment and at least one polyionic segment, and at least one charged surfactant having hydrophobic groups, the charge of the surfactant being opposite to that of the polyionic segment of the block copolymer. The constituents of the complex are bound by interaction between the opposite charges thereof and between surfactant hydrophobic groups. The complex may include an anionic surfactant having a biological activity, in which case the net charge of such anionic surfactant is no more than about 10.
    Type: Grant
    Filed: June 11, 1998
    Date of Patent: June 6, 2006
    Assignees: Univ. Nebraska Bd. of Regents, Moscow State Univ., McGill Univ.
    Inventors: Alexander V. Kabanov, Adi Eisenberg, Victor A. Kabanov
  • Publication number: 20030176406
    Abstract: The present invention relates to non-cross-linked micelles as delivery vehicles for steroid compounds and more particularly to a polycaprolactone-b-poly(ethylene oxide) copolymer micelle as a delivery vehicle for steroids. The delivery system comprises a population of diblock copolymer non-cross-linked micelles, each micelle defining a non-cross-linked core for containing the steroid compound. The delivery system of the present invention maintains the release of the steroid compound in a patient having a deficient steroid level.
    Type: Application
    Filed: December 10, 2002
    Publication date: September 18, 2003
    Applicant: McGill University
    Inventors: Christine Allen, Adi Eisenberg, Dusica Maysinger
  • Publication number: 20020169274
    Abstract: The present invention relates to diblock copolymers and more particularly to polycaprolactone-b-polyethylene oxide (PCL-b-PEO) diblock copolymers used in micellar systems, for delivering a biologically active agent to a site There is provided a diblock copolymer compound comprising a hydrophilic block and a hydrophobic block, the hydrophilic block comprising a polyethylene oxide (PEO) polymer, the hydrophobic block comprising a polycaprolactone (PCL) polymer, the PCL polymer comprising a number of caprolactone monomers selected from 5 to 150, the PEO polymer comprising a number of ethylene oxide monomers selected from 30 to 100. The diblock copolymer compound of the present invention may be used to form a micellar delivery system for delivering biologically active agents such as lipophilic drugs to sites such as the central nervous system.
    Type: Application
    Filed: June 26, 2002
    Publication date: November 14, 2002
    Inventors: Adi Eisenberg, Dusica Maysinger, Christine Allen
  • Patent number: 6469132
    Abstract: The present invention relates to diblock copolymers and more particularly to polycaprolactone-b-polyethylene oxide (PCL-b-PEO) diblock copolymers used in micellar systems, for delivering a biologically active agent to a site. There is provided a diblock copolymer compound comprising a hydrophilic block and a hydrophobic block, the hydrophilic block comprising a polyethylene oxide (PEO) polymer, the hydrophobic block comprising a polycaprolactone (PCL) polymer, the PCL polymer comprising a number of caprolactone monomers selected from 5 to 150, the PEO polymer comprising a number of ethylene oxide monomers selected from 30 to 100. The diblock copolymer compound of the present invention may be used to form a micellar delivery system for delivering biologically active agents such as lipophilic drugs to sites such as the central nervous system.
    Type: Grant
    Filed: May 3, 2000
    Date of Patent: October 22, 2002
    Assignee: McGill University
    Inventors: Adi Eisenberg, Dusica Maysinger, Christine Allen
  • Patent number: 4103044
    Abstract: Imaging material comprising a layer which comprises deformed particulate organic polymeric material such as flattened spheres, which has a memory for its original particulate shape and which is capable of recovering its original particulate shape upon the application of energy above a certain threshold. Examples of suitable particulate material include polystyrene, as it is obtained by emulsion or perl-polymerization in the presence of crosslinking agents, or polyethylene in particulate form, which has been crosslinked by the application of high energy radiation.
    Type: Grant
    Filed: November 26, 1976
    Date of Patent: July 25, 1978
    Assignee: Energy Conversion Systems, Inc.
    Inventors: Adi Eisenberg, Stanford R. Ovshinsky